Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma

Mathew R. Birnbaum, Michelle W. Ma, Sarah Fleisig, Stuart Packer, Bijal D. Amin, Mark Jacobson, Beth N. McLellan

Research output: Contribution to journalArticle

27 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)208-211
Number of pages4
JournalJAAD Case Reports
Volume3
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Sarcoidosis
Immunotherapy
Skin
nivolumab
Adenocarcinoma of lung

Keywords

  • immune checkpoint inhibitors
  • immune-related adverse events
  • immunotherapy
  • nivolumab
  • programmed cell death-1
  • sarcoidosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma. / Birnbaum, Mathew R.; Ma, Michelle W.; Fleisig, Sarah; Packer, Stuart; Amin, Bijal D.; Jacobson, Mark; McLellan, Beth N.

In: JAAD Case Reports, Vol. 3, No. 3, 01.05.2017, p. 208-211.

Research output: Contribution to journalArticle

Birnbaum, Mathew R. ; Ma, Michelle W. ; Fleisig, Sarah ; Packer, Stuart ; Amin, Bijal D. ; Jacobson, Mark ; McLellan, Beth N. / Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma. In: JAAD Case Reports. 2017 ; Vol. 3, No. 3. pp. 208-211.
@article{74556530fe93439fae7f95222274756d,
title = "Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma",
keywords = "immune checkpoint inhibitors, immune-related adverse events, immunotherapy, nivolumab, programmed cell death-1, sarcoidosis",
author = "Birnbaum, {Mathew R.} and Ma, {Michelle W.} and Sarah Fleisig and Stuart Packer and Amin, {Bijal D.} and Mark Jacobson and McLellan, {Beth N.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.jdcr.2017.02.015",
language = "English (US)",
volume = "3",
pages = "208--211",
journal = "JAAD Case Reports",
issn = "2352-5126",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma

AU - Birnbaum, Mathew R.

AU - Ma, Michelle W.

AU - Fleisig, Sarah

AU - Packer, Stuart

AU - Amin, Bijal D.

AU - Jacobson, Mark

AU - McLellan, Beth N.

PY - 2017/5/1

Y1 - 2017/5/1

KW - immune checkpoint inhibitors

KW - immune-related adverse events

KW - immunotherapy

KW - nivolumab

KW - programmed cell death-1

KW - sarcoidosis

UR - http://www.scopus.com/inward/record.url?scp=85017534907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017534907&partnerID=8YFLogxK

U2 - 10.1016/j.jdcr.2017.02.015

DO - 10.1016/j.jdcr.2017.02.015

M3 - Article

AN - SCOPUS:85017534907

VL - 3

SP - 208

EP - 211

JO - JAAD Case Reports

JF - JAAD Case Reports

SN - 2352-5126

IS - 3

ER -